Trial intelligence / Profile preview

Oral magnesium and calcitriol for magnesium deficiency after renal transplantation

ChiCTR-TRC-12002432Phase 4Completed

Sponsor
The Third Medical Center of the Chinese People's Liberation Army General Hospital
Start
Sep 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of magnesium and calcitriol in hypomagnesaemia (4 arms), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoints: Serum magnesium and Electrolytes. Started Sep 2012; status: completed.

02

Drugs

magnesiumcalcitriol
03

Conditions

hypomagnesaemia

Beyond the preview

Go deeper on ChiCTR-TRC-12002432.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002432.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call